Table 3.
Decision task condition.
Region | Hemisphere | Cluster peak coordinatesa | Pb | kE |
---|---|---|---|---|
DEC task rCBF increases following 1 week of APD treatment, SZ1 > SZ0 | ||||
Putamen | L | −26, 6, −6 | 0.000 | 646 |
Putamen | R | 30, 14, −6 | 0.000 | 132 |
Putamen | R | 28, 6, −6 | 0.021 | 41 |
DEC task rCBF decreases following 1 week of APD treatment, SZ1 < SZ0 | ||||
Anterior cingulate cortex | L, R | 4, 10, 40 | 0.037 | 41 |
DEC task rCBF increases following 6 weeks of APD treatment, SZ6 > SZ0 | ||||
Putamen | L | −36, −4, −4 | 0.000 | 153 |
Putamen | R | 24, 6, −2 | 0.000 | 150 |
Putamen | L | −18, 14, −8 | 0.006 | 60 |
DEC task rCBF decreases following 6 weeks of APD treatment, SZ6 < SZ0 | ||||
Medial frontal gyrus | L, R | 0, 50, 18 | 0.011 | 53 |
DEC task rCBF increases between week 1 and week six of APD treatment, SZ6 < SZ1 | ||||
Putamen | L | −26, 4, −6 | 0.005 | 55 |
aMontreal Neurological Institute (MNI) anatomical coordinates in x, y, z.
bp values FDR corrected.
SZ0, baseline; SZ1, after 1 week of antipsychotic drugs treatment; SZ6, after 6 weeks of antipsychotic drug treatment; APDs, antipsychotic drugs; R, right; L, left; kE, kernel extent in voxels; rCBF, regional cerebral blood flow.
Regional cerebral blood flow changes during decision task from baseline after 1 and 6 weeks of treatment and between 1 and 6 weeks of treatment.